Literature DB >> 6611601

Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state.

R A Stockley, S L Hill, H M Morrison.   

Abstract

Broad spectrum antibiotic treatment was given on 21 occasions to 15 patients with bronchiectasis who regularly produced purulent, elastase positive secretions. Although the results showed that sputum clearing--that is, changing from purulent to mucoid--largely depended on the pathogenic organism isolated, this was not exclusively the case and in some cases sputum growing sensitive organisms failed to clear whereas clearing occurred in other samples containing resistant organisms or no obvious pathogens. Clearing of sputum was achieved eventually in 12 of the patients and this was associated with the disappearance of elastase activity, although it returned in 10 patients within one week of stopping treatment. There was no change in sputum elastase where the sputum failed to clear. The clearance of elastase activity was associated with a decrease in protein transudation into the lung secretions. The sputum:serum albumin concentration ratio fell (p less than 0.005) from a mean (SD) of 2.32 (1.56) X 10(-2) in these 12 patients before treatment to 1.09 (0.40) X 10(-2) within the first week of treatment, but rose again to 2.07 (1.29) X 10(-2) within one week of stopping treatment. The results suggest that antibiotic treatment when patients are in a stable state may have a beneficial effect on the pathogenic nature of lung secretions and inflammation within the lung.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611601      PMCID: PMC459822          DOI: 10.1136/thx.39.6.414

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  Patterns of distribution and clearance of aerosols in patients with bronchiectasis.

Authors:  R V Lourenço; R Loddenkemper; R W Carton
Journal:  Am Rev Respir Dis       Date:  1972-12

2.  Inhibition of leukocytic elastase from purulent sputum by alpha 1 -antitrypsin.

Authors:  J Lieberman; W Kaneshiro
Journal:  J Lab Clin Med       Date:  1972-07

3.  Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection.

Authors:  D E Roberts; P Cole
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

Review 4.  Proteolytic enzymes, their inhibitors and lung diseases.

Authors:  R A Stockley
Journal:  Clin Sci (Lond)       Date:  1983-02       Impact factor: 6.124

5.  Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease.

Authors:  J Wiggins; J A Elliott; R D Stevenson; R A Stockley
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

6.  Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis.

Authors:  R A Stockley; S L Hill; H M Morrison; C M Starkie
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

7.  Alpha,-antitrypsin and leukocyte elastase in infected and noninfected sputum.

Authors:  R A Stockley; D Burnett
Journal:  Am Rev Respir Dis       Date:  1979-11

8.  Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum.

Authors:  K Ohlsson; H Tegner
Journal:  Eur J Clin Invest       Date:  1975-06-12       Impact factor: 4.686

9.  A simple oral antimicrobial regimen effective in severe chronic bronchial suppuration associated with culturable Haemophilus influenzae.

Authors:  P J Cole; D E Roberts; S F Davies; R K Knight
Journal:  J Antimicrob Chemother       Date:  1983-02       Impact factor: 5.790

10.  Effect of human leukocyte enzymes on tracheal mucosa and its mucociliary activity.

Authors:  H Tegner; K Ohlsson; N G Toremalm; C von Mecklenburg
Journal:  Rhinology       Date:  1979-09       Impact factor: 3.681

View more
  10 in total

Review 1.  Lung infections. 1. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection.

Authors:  R A Stockley
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

2.  Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation.

Authors:  S L Hill; H M Morrison; D Burnett; R A Stockley
Journal:  Thorax       Date:  1986-07       Impact factor: 9.139

3.  Chronic bronchial sepsis and progressive lung damage.

Authors:  G M Cochrane
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-06

4.  Simple method for quantifying viable bacterial numbers in sputum.

Authors:  A Pye; R A Stockley; S L Hill
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

5.  Activities and sources of beta-lactamase in sputum from patients with bronchiectasis.

Authors:  P Dragicevic; S L Hill; D Burnett; D Merrikin; R A Stockley
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 6.  Severe bronchiectasis.

Authors:  Brian M Morrissey; Samuel J Evans
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

7.  Effect of cigarette smoking, pulmonary inflammation, and lung disease on concentrations of carcinoembryonic antigen in serum and secretions.

Authors:  R A Stockley; J Shaw; A G Whitfield; T P Whitehead; C A Clarke; D Burnett
Journal:  Thorax       Date:  1986-01       Impact factor: 9.139

Review 8.  Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults.

Authors:  Khin Hnin; Chau Nguyen; Kristin V Carson; David J Evans; Michael Greenstone; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2015-08-13

Review 9.  Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review.

Authors:  Xia-Yi Miao; Xiao-Bin Ji; Hai-Wen Lu; Jia-Wei Yang; Jin-Fu Xu
Journal:  Chin Med J (Engl)       Date:  2015-10-20       Impact factor: 2.628

10.  Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.

Authors:  Roshan Siva; Mona Bafadhel; William Monteiro; Christopher E Brightling; Ian D Pavord
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.